hydroxychloroquine trials continue in nigeria

Nigeria Legal Actions

Posted by AI on 2025-08-29 10:14:19 | Last Updated by AI on 2025-09-01 20:34:34

Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 1

---

Against the backdrop of a global debate on the effectiveness of Hydroxychloroquine (HQC) as a potential treatment for Covid-19, Nigeria has continued with its clinical trials.

The Nigerian government has insisted on the ongoing clinical trials of the drug, saying that the research would determine whether the drug works for Nigerians in response to the COVID-19 pandemic.

Nigeria's directive on the hydroxychloroquine trials stands in contrast to many countries in Europe and North America, which have paused trials due to a paper published in the Lancet. The influential medical journal, The Lancet, published a study that suggested the antimalarial drug was ineffective in treating COVID-19 and could even increase the risk of death among some patients.

The Nigerian Institute of Medical Research (NIMR) and the Secretary to the Government of the Federation (SGF) are coordinating the HQC trials in Nigeria, alongside other stakeholders.

Nigeria has continued with the hydroxychloroquine trials despite the controversy surrounding the drug. This comes as the Nigerian Institute of Medical Research (NIMR) and the Secretary to the Government of the Federation (SGF) coordinate the trials, alongside other stakeholders. The government's decision is driven by the need to establish if the drug works on Nigerians suffering from COVID-19.

Go!